β-trace protein: A marker of cerebrospinal fluid fistulas

被引:1
作者
Tabaouti, K. [1 ]
Kraoul, L. [1 ]
Lancelin, F. [1 ]
Alyoussef, L. [1 ]
Brovedani, S. [1 ]
Abi-Lahoud, G. [2 ]
Piketty, M. L. [1 ]
机构
[1] Ctr Hosp St Anne, Lab Cent Biol, F-75014 Paris, France
[2] Ctr Hosp St Anne, Serv Neurochirurg, F-75014 Paris, France
来源
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE | 2008年 / 23卷 / 04期
关键词
beta-trace protein; Cerebrospinal fluid fistula; Nephelometry;
D O I
10.1016/j.immbio.2008.07.001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives. - beta-trace protein is a valuable marker of cerebrospinal fluid (CSF) leakage. However, there is still a controversy about the appropriate cut off to be used (range 0.35-6 mg/L). The aim of this study was to evaluate the nephelometric beta-trace protein assay for the diagnosis of liquorrhea. Patients and method. - A total of 20 samples of CSF and serum from control patients and 36 specimens from patients with liquorrhea were analysed. Results. - The mean concentration of p-trace protein was 0.59 +/- 0.13 mg/L in serum of control patients and 17.6 +/- 5.8 mg/L in CSF. At a cut off of 1.1 mg/L, specificity was 100% with a sensitivity of 96%. Conclusion. - Nephelometric measurement of P-trace protein is a noninvasive and fast method that can be used for CSF leakage diagnosis. It should be kept in mind, however, that the cut off of 1.1 mg/L is not suitable for patients with bacterial meningitis and those with reduced glomerular filtration. (C) 2008 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:212 / 219
页数:8
相关论文
共 22 条
  • [1] Arrer E, 2002, CLIN CHEM, V48, P939
  • [2] Predictive values of β-trace protein (prostaglandin D synthase) by use of laser-nephelometry assay for the identification of cerebrospinal fluid
    Bachmann, G
    Petereit, H
    Djenabi, U
    Michel, O
    [J]. NEUROSURGERY, 2002, 50 (03) : 571 - 576
  • [3] Traumatic cerebrospinal fluid leakage: Risk factors and the use of prophylactic antibiotics
    Choi, D
    Spann, R
    [J]. BRITISH JOURNAL OF NEUROSURGERY, 1996, 10 (06) : 571 - 575
  • [4] Management of cerebrospinal fluid fistulae: physiopathology, imaging and treatment
    Domengie, F
    Cottier, JP
    Lescanne, E
    Aesch, B
    Vinikoff-Sonier, C
    Gallas, S
    Herbreteau, D
    [J]. JOURNAL OF NEURORADIOLOGY, 2004, 31 (01) : 47 - 59
  • [5] Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice
    Eguchi, N
    Minami, T
    Shirafuji, N
    Kanaoka, Y
    Tanaka, T
    Nagata, A
    Yoshida, N
    Urade, Y
    Ito, S
    Hayaishi, O
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) : 726 - 730
  • [6] BETA-TRACE-PROTEIN AS MARKER FOR CEREBROSPINAL-FLUID FISTULA
    FELGENHAUER, K
    SCHADLICH, HJ
    NEKIC, M
    [J]. KLINISCHE WOCHENSCHRIFT, 1987, 65 (16): : 764 - 768
  • [7] Filler G, 2002, CLIN CHEM, V48, P729
  • [8] What is "spontaneous" cerebrospinal fluid rhinorrhea? Classification of cerebrospinal fluid leaks
    Har-El, G
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1999, 108 (04) : 323 - 326
  • [9] HOFFMANN A, 1993, J NEUROCHEM, V61, P451
  • [10] Comprehensive algorithm for skull base dural lesion and cerebrospinal fluid fistula diagnosis
    Meco, C
    Oberascher, G
    [J]. LARYNGOSCOPE, 2004, 114 (06) : 991 - 999